المؤلفون: BARO, FRANCESC, Goya Canino, Maria del Mar, Suárez-Edo, Elena, Pancorbo Lerma, Maria Luisa, Ferreira González, Ignacio, Carreras, Elena, Pijuan-Domenech, Antonia, Miranda, Berta, DOS SUBIRA, LAURA

المساهمون: Institut Català de la Salut, Baró-Mariné F, Goya MDM, Pancorbo ML, Carreras-Moratonas E Servei d’Obstetrícia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Pijuan-Domènech A, Miranda-Barrio B, Dos-Subirà L Unitat de Cardiopaties Congènites de l’Adolescent i l’Adult Vall d’Hebron Hospital Universitari, Barcelona, Spain. Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER-CV, Barcelona, Spain. Suárez-Edo E Servei d’Anestesiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Ferreira-Gonzalez I Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER-CV, Barcelona, Spain. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER-ESP, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Cardiopatia congènita, Contraceptius, Progesterona, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Reproductive Techniques::Contraception, DISEASES::Cardiovascular Diseases::Cardiovascular Abnormalities::Heart Defects, Congenital, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Progestins, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::técnicas reproductivas::anticoncepción, ENFERMEDADES::enfermedades cardiovasculares::anomalías cardiovasculares::cardiopatías congénitas, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::hormonas, sustitutos de hormonas y antagonistas de hormonas::hormonas::progestágenos

وصف الملف: application/pdf

العلاقة: Journal of Obstetrics and Gynaecology;44(1); https://doi.org/10.1080/01443615.2024.2320296Test; Baró-Mariné F, Pijuan-Domènech A, Del Mar Goya M, Suárez-Edo E, Miranda-Barrio B, Dos-Subirà L, et al. Progestogen only contraception in women with congenital heart disease. J Obstet Gynaecol (Lahore). 2024 Mar 11;44(1):2320296.; https://hdl.handle.net/11351/11201Test

الإتاحة: https://doi.org/10.1080/01443615.2024.2320296Test
https://hdl.handle.net/11351/11201Test

المؤلفون: Matsubara, Nobuaki, Agarwal, Neeraj, Saad, Fred, Azad, Arun, Mateo, Joaquin, Shore, Neal

المساهمون: Institut Català de la Salut, Agarwal N Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Saad F University of Montréal Hospital Center, Montréal, Québec, Canada. Azad AA Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Mateo J Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Matsubara N National Cancer Center Hospital East, Chiba, Japan. Shore ND Carolina Urologic Research Center, Myrtle Beach, SC, USA, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pròstata - Càncer - Tractament, Metàstasi, Antiandrògens - Receptors, DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormone Antagonists::Androgen Antagonists::Androgen Receptor Antagonists, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols, DISEASES::Neoplasms::Neoplastic Processes::Neoplasm Metastasis, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::hormonas, sustitutos de hormonas y antagonistas de hormonas::antagonistas de hormonas::antagonistas de andrógenos::antagonistas de receptores de andrógenos, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada, ENFERMEDADES::neoplasias::procesos neoplásicos::metástasis neoplásica

وصف الملف: application/pdf

العلاقة: Future Oncology;20(9); https://doi.org/10.2217/fon-2023-0526Test; Agarwal N, Saad F, Azad AA, Mateo J, Matsubara N, Shore ND, et al. TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer. Futur Oncol. 2023 Oct 26;20(9):493–505.; https://hdl.handle.net/11351/11252Test; 001087207700001

الإتاحة: https://doi.org/10.2217/fon-2023-0526Test
https://hdl.handle.net/11351/11252Test

المؤلفون: Mayer, Ingrid, Winer, Eric, Linden, Hannah, Ma, Cynthia X., Parker, Barbara A., Bellet Ezquerra, Meritxell, Bardia, Aditya

المساهمون: Institut Català de la Salut, Bardia A Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Mayer I Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. AstraZeneca, Gaithersburg, MD, USA. Winer E Dana-Farber Cancer Institute, Boston, MA, USA. Yale Cancer Center, New Haven, CT, USA. Linden HM University of Washington, Seattle, WA, USA. Ma CX Washington University School of Medicine, St. Louis, MO, USA. Parker BA University of California San Diego Moores Cancer Center, San Diego, CA, USA. Bellet M Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Estrògens - Antagonistes - Ús terapèutic, Menopausa, Mama - Càncer - Tractament, DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormone Antagonists::Estrogen Antagonists, Other subheadings::Other subheadings::/therapeutic use, PHENOMENA AND PROCESSES::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Climacteric::Menopause::Postmenopause, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::hormonas, sustitutos de hormonas y antagonistas de hormonas::antagonistas de hormonas::antagonistas de estrógenos, Otros calificadores::Otros calificadores::/uso terapéutico, FENÓMENOS Y PROCESOS::fenómenos fisiológicos reproductivos y urinarios::fenómenos fisiológicos de la reproducción::climaterio::menopausia::posmenopausia

وصف الملف: application/pdf

العلاقة: Breast Cancer Research and Treatment;197; https://doi.org/10.1007/s10549-022-06797-9Test; Bardia A, Mayer I, Winer E, Linden HM, Ma CX, Parker BA, et al. The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer. Breast Cancer Res Treat. 2023 Jan;197:319–31.; https://hdl.handle.net/11351/9315Test; 000885413200001

الإتاحة: https://doi.org/10.1007/s10549-022-06797-9Test
https://hdl.handle.net/11351/9315Test

المؤلفون: Gil Martínez, Marta, Lorente-Sorolla, Clara, Rodrigo Muñoz, José Manuel, Lendínez, Miguel Ángel, Núñez-Moreno, Gonzalo, de la Fuente, Lorena, Muñoz Gall, Fco. Javier, Cruz Carmona, Mª Jesús

المساهمون: Institut Català de la Salut, Gil-Martínez M, Rodrigo-Muñoz JM Immunoallergy Laboratory, Immunology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain. CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Lorente-Sorolla C, Lendínez MÁ Immunoallergy Laboratory, Immunology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain. Núñez-Moreno G Department of Genetics, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain. Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Bioinformatics Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain. de la Fuente L Department of Genetics, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain. Muñoz X, Cruz MJ CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Asma - Tractament, Glucocorticoides - Ús terapèutic, MicroARN, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Glucocorticoids, Other subheadings::Other subheadings::/therapeutic use, CHEMICALS AND DRUGS::Nucleic Acids, Nucleotides, and Nucleosides::Antisense Elements (Genetics)::RNA, Antisense::MicroRNAs, DISEASES::Respiratory Tract Diseases::Bronchial Diseases::Asthma, Other subheadings::Other subheadings::Other subheadings::/drug therapy, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::hormonas, sustitutos de hormonas y antagonistas de hormonas::hormonas::glucocorticoides, Otros calificadores::Otros calificadores::/uso terapéutico, COMPUESTOS QUÍMICOS Y DROGAS::nucleótidos y nucleósidos de ácidos nucleicos::elementos antisentido (genética)::ARN antiparalelo::microARN, ENFERMEDADES::enfermedades respiratorias::enfermedades bronquiales::asma, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia

وصف الملف: application/pdf

العلاقة: International Journal of Molecular Sciences;24(2); https://doi.org/10.3390/ijms24021611Test; Gil-Martínez M, Lorente-Sorolla C, Rodrigo-Muñoz JM, Lendínez MÁ, Núñez-Moreno G, de la Fuente L, et al. Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids. Int J Mol Sci. 2023 Jan 13;24(2):1611.; https://hdl.handle.net/11351/9035Test

الإتاحة: https://doi.org/10.3390/ijms24021611Test
https://hdl.handle.net/11351/9035Test

المؤلفون: Zurita, Amado J., Graf, Ryon, Raskina, Kira, Sokol, Ethan, Jin, Dexter, Casanova Salas, Irene, Villacampa Javierre, Guillermo, Vivancos, Ana, Carles, Joan, Mateo, Joaquin

المساهمون: Institut Català de la Salut, Zurita AJ The University of Texas MD Anderson Cancer Center, Houston, TX. Graf RP, Raskina K, Sokol E, Jin D Foundation Medicine Inc, Cambridge, MA. Villacampa G, Casanova-Salas I, Vivancos A, Carles J, Mateo J Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Marcadors tumorals, Pròstata - Càncer - Tractament, Andrògens - Ús terapèutic, DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms::Prostatic Neoplasms, Castration-Resistant, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Biological Factors::Biomarkers::Biomarkers, Tumor, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Androgens, Other subheadings::Other subheadings::/therapeutic use, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata::neoplasias prostáticas resistentes a la castración, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores::marcadores tumorales, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::hormonas, sustitutos de hormonas y antagonistas de hormonas::hormonas::andrógenos, Otros calificadores::Otros calificadores::/uso terapéutico

وصف الملف: application/pdf

العلاقة: JCO Precision Oncology;6; https://doi.org/10.1200/PO.22.00195Test; Zurita AJ, Graf RP, Villacampa G, Raskina K, Sokol E, Jin D, et al. Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies. JCO Precis Oncol. 2022 Jul;6:e2200195.; https://hdl.handle.net/11351/9670Test; 000975488400076

الإتاحة: https://doi.org/10.1200/PO.22.00195Test
https://hdl.handle.net/11351/9670Test

المؤلفون: Boutriq, Soukaina, González-González, Alicia, Plaza-Andrades, Isaac, Laborda-Illanes, Aurora, Sánchez-Alcoholado, Lidia, Peralta-Linero, Jesús, Domínguez-Recio, María Emilia, Bermejo-Pérez, María José, Lavado-Valenzuela, Rocío, Alba, Emilio, Queipo-Ortuño, María Isabel

المساهمون: [Boutriq,S, González-González,A, Plaza-Andrades,I, Laborda-Illanes,A, Sánchez-Alcoholado,L, Peralta-Linero,J, Domínguez-Recio,ME, Bermejo-Pérez,MJ, Alba, Queipo-Ortuño,MI] Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA)-CIMES-UMA, Málaga, Spain. [Boutriq,S, Lavado-Valenzuela,R, Queipo-Ortuño,MI] Instituto de Investigación Biomédica de Málaga (IBIMA), Campus de Teatinos s/n, Málaga, Spain. [Boutriq,S, Sánchez-Alcoholado,L] Facultad de Medicina, Universidad de Málaga, Málaga, Spain. [Queipo-Ortuño,MI] Centro de Investigación Biomédica en Red de Cáncer (Ciberonc CB16/12/00481), Madrid, Spain., Maria Isabel Queipo-Ortuño is recipient of a 'Miguel Servet Type II' program (CPI13/00003) from ISCIII, co-funded by the Fondo Europeo de Desarrollo Regional-FEDER, Madrid, Spain and also belongs to the regional 'Nicolas Monardes' research program of the Consejería de Salud (C-0030-2018, Junta de Andalucía, Spain. Alicia González-González is recipient of a postdoctoral contract of ALIANZA MIXTA EN RED ANDALUCÍA-ROCHE EN ONCOLOGÍA MÉDICA DE PRECISIÓN (INVESTIGACIÓN BÁSICA/TRASLACIONAL). Aurora Laborda-Illanes was recipient of a predoctoral grant, PFIS-ISCIII (FI19-00112) co-funded by the Fondo Europeo de Desarrollo Regional-FEDER, Madrid, Spain. Lidia Sanchez-Alcoholado was recipient of a predoctoral grant (PE-0106-2019) from the Consejería de Salud y Familia (co-funded by the Fondo Europeo de Desarrollo Regional-FEDER, Andalucia, Spain).

مصطلحات موضوعية: Inflammation, Gut microbiome, Prebióticos, Endometrial microbiome, Estrogen metabolism, Microbioma gastrointestinal, Inflamación, Probiotics, Disbiosis, Anatomy::Urogenital System::Genitalia::Genitalia, Female::Uterus [Medical Subject Headings], Probióticos, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Estrogens [Medical Subject Headings], Prebiotics, Phenomena and Processes::Microbiological Phenomena::Microbiota [Medical Subject Headings], Endometrial cancer, Dysbiosis, Neoplasias endometriales, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis [Medical Subject Headings], Estrobolome, Disciplines and Occupations::Natural Science Disciplines::Biological Science Disciplines::Biochemistry::Molecular Biology [Medical Subject Headings], Antitumour treatment, Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Inflammation [Medical Subject Headings], Diseases::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Endometrial Neoplasms [Medical Subject Headings]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______2636::5d5cb58621e3528db362138c8b09ae32Test
https://hdl.handle.net/10668/3658Test

المؤلفون: Regina Allande-Cussó, Mónica Ortega-Moreno, Javier Fagundo-Rivera, Juan Jesús García-Iglesias, Adolfo Romero, Carlos Ruiz-Frutos, Juan Gómez-Salgado

المساهمون: [Fagundo-Rivera,J] Health Sciences Doctorate School, University of Huelva, Huelva, Spain. [Fagundo-Rivera,J] Centro Universitario de Enfermería Cruz Roja, University of Seville, Seville, Spain. [Fagundo-Rivera,J] Escola Superior de Saúde, Universidade Atlântica, Barcarena, Portugal. [Allande-Cussó,R] Department of Nursing, University of Sevilla, Sevilla, Spain. [Ortega-Moreno,M] Department of Economy, Faculty of Labour Sciences, University of Huelva, Huelva, Spain. [García-Iglesias,JJ, Ruiz-Frutos,C, Gómez-Salgado,J] Department of Sociology, Social Work and Public Health, Faculty of Labour Sciences, University of Huelva, Huelva, Spain. [Romero,A] Nursing and Podiatry Department, Health Sciences School, University of Malaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain. [Ruiz-Frutos,C, Gómez-Salgado,J] Safety and Health Postgraduate Programme, Espíritu Santo University, Guayaquil, Ecuador., This research was part of the project 'Working exposure to breast cancer risk factors: night work in nursing' which was funded by the Andalusian Institute for the Prevention of Occupational Hazards (IAPRL) 17 June 2019., Universidad de Sevilla. Departamento de Enfermería, Esta investigación fue parte del proyecto 'Exposición laboral a factores de riesgo de cáncer de mama: trabajo en enfermería 'que fue financiado por el Instituto Andaluz de Prevención de las Enfermedades Laborales Peligros (IAPRL) 17 de junio de 2019.

المصدر: Healthcare, Vol 9, Iss 649, p 649 (2021)
Healthcare
Volume 9
Issue 6
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
Arias Montano. Repositorio Institucional de la Universidad de Huelva

مصطلحات موضوعية: Shift work, night work, Logistic regression, Diseases::Skin and Connective Tissue Diseases::Skin Diseases::Breast Diseases::Breast Neoplasms [Medical Subject Headings], health personnel, carcinogens, Carcinógenos, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], 0302 clinical medicine, Breast cancer, Health Information Management, prevention, Medicine, Equilibrio entre vida personal y laboral, 030212 general & internal medicine, Persons::Persons::Occupational Groups::Health Personnel::Nurses [Medical Subject Headings], Working life, education.field_of_study, Chemicals and Drugs::Chemical Actions and Uses::Toxic Actions::Noxae::Carcinogens [Medical Subject Headings], Health Policy, Incidence (epidemiology), Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cross-Sectional Studies [Medical Subject Headings], Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Estrogens [Medical Subject Headings], 030220 oncology & carcinogenesis, Neoplasias de la mama, Enfermedades profesionales, Condiciones de trabajo, Personal de salud, Leadership and Management, Population, Occupational disease, Working conditions, Health Informatics, Horario de trabajo por turnos, Article, 03 medical and health sciences, breast cancer, 32 Ciencias Médicas, education, Night work, Diseases::Nervous System Diseases::Chronobiology Disorders [Medical Subject Headings], Enfermeras, Prevención de enfermedades, business.industry, Prevention, working conditions, Diseases::Neoplasms::Neoplasms by Site::Mammary Neoplasms, Animal [Medical Subject Headings], Psychiatry and Psychology::Behavior and Behavior Mechanisms::Psychology, Social::Life Style [Medical Subject Headings], Health personnel, medicine.disease, Persons::Persons::Occupational Groups::Health Personnel [Medical Subject Headings], shift work, Check Tags::Female [Medical Subject Headings], occupational disease, Carcinogens, business, Trastornos cronobiológicos, Demography

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e806b1233d2c67256a87aaa163d9d16Test
https://hdl.handle.net/10668/17923Test

المؤلفون: Ignacio Puche-Sanz, Pedro J. Real, Pablo Lupiañez, Sonia Perales, Iris Simon, Clara Alaminos, José A. Lorente, Alba Rodríguez-Martínez, Laura Casado-Medina, Juan J. Díaz-Mochón, María José Serrano, María del Carmen Garrido-Navas

المساهمون: [Simon,I, Perales,S, Casado-Medina,L, Lupiañez,P, Real,PJ] GENyO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Gene Regulation, Stem Cells & Development Lab, PTS Granada, Granada, Spain. [Simon,I, Real,PJ] Faculty of Science, Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain. [Rodríguez-Martínez,A, Garrido-Navas,MDC, Lorente,JA, Serrano,MJ] GENyO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Liquid Biopsy and Cancer Interception Group, PTS Granada, Granada, Spain. [Rodríguez-Martínez,A, Lorente,JA] Faculty of Medicine, Legal Medicine and Toxicology Department, University of Granada, Laboratory of Genetic Identification, Spain. [Garrido-Navas,MDC] Universidad Internacional de la Rioja, Logroño, Spain. [Puche-Sanz,I] Department of Urology, Bio-Health Research Institute (Instituto de Investigación Biosanitaria ibs.GRANADA), Hospital Universitario Virgen de las Nieves, University of Granada, Granada, Spain. [Diaz-Mochon, JJ] GENyO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Nanochembio Lab, PTS Granada, Granada, Spain. [Diaz-Mochon,JJ] Department of Pharmaceutical and Organic Chemistry, Faculty of Pharmacy, Campus de Cartuja, University of Granada, Granada, Spain. [Alaminos,C] Department of Urology, University Hospital of Jaen, Jaen, Spain. [Serrano,MJ] Comprehensive Oncology Division, Clinical University Hospital, Virgen de las Nieves-IBS, Granada, Spain. [Serrano,MJ] Department of Pathological Anatomy, Faculty of Medicine, University of Granada, Granada, Spain. [Real, PJ] Bio-Health Research Institute (Instituto de Investigación Biosanitaria ibs.GRANADA), Personalized Oncology Group, Granada, Spain, This study was supported by the Institute of Health Carlos III, Spain (PI17/00989) to M.J.S. and cofunded by the European Regional Development Fund 'A way to build Europe' and the Ramon y Cajal (RYC-2015-18382) to P.J.R., funded by the Ministry of Economy and Competitiveness. A.R.-M. was supported by the predoctoral-University Teacher Training Program from the Ministry of Education, Culture and Sport (FPU14/05461), I.S. was supported by the Young Researcher program from University of Granada (Joven Personal Investigador-Fondo Social Europeo, Universidad de Granada (2018-19)) and a donation from Rolucan Association (Rota Lucha contra el Cancer).

المصدر: Cancers
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Cancers, Vol 13, Iss 1483, p 1483 (2021)
Volume 13
Issue 6

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Phenomena and Processes::Genetic Phenomena::Phenotype [Medical Subject Headings], castration resistant prostate cancer, Cell, Andrógenos, urologic and male genital diseases, Diseases::Male Urogenital Diseases::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms::Prostatic Neoplasms, Castration-Resistant [Medical Subject Headings], Androgen deprivation therapy, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Castration Resistance, Anatomy::Cells::Cells, Cultured::Cell Line [Medical Subject Headings], androgen receptor, abiraterone, transcriptional regulation, Abiraterone, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Cytophotometry::Flow Cytometry [Medical Subject Headings], medicine.diagnostic_test, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Protein Isoforms [Medical Subject Headings], enzalutamide, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Androgen receptor, medicine.anatomical_structure, Elementos reguladores de la transcripción, Oncology, Chemicals and Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormone Antagonists::Androgen Antagonists [Medical Subject Headings], 030220 oncology & carcinogenesis, Castration resistant prostate cancer, cross-resistance, Check Tags::Male [Medical Subject Headings], lcsh:RC254-282, Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulation::RNA Processing, Post-Transcriptional::RNA Splicing::Alternative Splicing [Medical Subject Headings], Article, Flow cytometry, 03 medical and health sciences, Transcriptional regulation, Psychiatry and Psychology::Behavior and Behavior Mechanisms::Motivation::Goals [Medical Subject Headings], Acetato de abiraterona, medicine, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Androgens [Medical Subject Headings], Enzalutamide, Cross-resistance, Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Growth Processes::Cell Proliferation [Medical Subject Headings], Cell growth, business.industry, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Urogenital Surgical Procedures::Castration [Medical Subject Headings], Neoplasias de la próstata resistentes a la castración, medicine.disease, 030104 developmental biology, chemistry, Novel hormonal agents, Cancer research, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Receptors, Cytoplasmic and Nuclear::Receptors, Steroid::Receptors, Androgen [Medical Subject Headings], business, AR-V7, AR-V9

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f963c522f34e705bb01ae3faeed08e75Test
http://europepmc.org/articles/PMC8004828Test

المؤلفون: Rafael Sánchez-Sánchez, Raúl M. Luque, Manuel D. Gahete, Enrique Gómez-Gómez, Vicente Herrero-Aguayo, Justo P. Castaño, Prudencio Sáez-Martínez, Antonio J. Montero Hidalgo, Antonio J. León-González, Juan M. Jiménez-Vacas, M.J. Requena-Tapia

المساهمون: [Sáez-Martínez,P, Jiménez-Vacas,JM, León-González,AJ, Herrero-Aguayo,V, Montero Hidalgo,AJ, Gómez-Gómez,E, Sánchez-Sánchez,R, Requena-Tapia,MJ, Castaño,JP, Gahete,MD, Luque,RM] Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Cordoba, Spain. [Sáez-Martínez,P, Luque,RM] Department of Cell Biology, Physiology, and Immunology, University of Córdoba, Cordoba, Spain. [Sáez-Martínez,P, Luque,RM] Hospital Universitario Reina Sofía (HURS), Cordoba, Spain. [Sáez-Martínez,P, Luque,RM] Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, (CIBERobn), Cordoba, Spain. [Gómez-Gómez,E, Requena-Tapia,MJ] Urology Service, HURS/IMIBIC, Cordoba, Spain. [Sánchez-Sánchez,R] Anatomical Pathology Service, HURS, Cordoba, Spain., This research was funded by Instituto de Salud Carlos III, co-funded by European Union (ERDF/ESF, 'Investing in your future') [PI16/00264, PI17/02287, CD16/00092], MINECO/MECD (FPU17/00263, FPU16/06190, FPU18/02485, BFU2016-80360-R), Junta de Andalucia (BIO-0139), and CIBERobn. CIBER is an initiative of Instituto de Salud Carlos III, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain.

المصدر: Journal of Clinical Medicine, Vol 9, Iss 1703, p 1703 (2020)
Journal of Clinical Medicine
Volume 9
Issue 6
Journal of Clinical Medicine 9(6), 1703 (2020)
Helvia. Repositorio Institucional de la Universidad de Córdoba
instname
Helvia: Repositorio Institucional de la Universidad de Córdoba
Universidad de Córdoba

مصطلحات موضوعية: 0301 basic medicine, Diagnostic/prognostic biomarker, Phenomena and Processes::Genetic Phenomena::Phenotype [Medical Subject Headings], castration resistant prostate cancer, Neoplasias de la próstata, Anatomy::Urogenital System::Genitalia::Genitalia, Male::Prostate [Medical Subject Headings], Cell, neuronostatin, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, G-Protein-Coupled [Medical Subject Headings], lcsh:Medicine, MMP9, Splicing, Diseases::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms::Prostatic Neoplasms, Castration-Resistant [Medical Subject Headings], urologic and male genital diseases, Metastasis, Somatostatin-system, Prostate cancer, 0302 clinical medicine, Information Science::Information Science::Computing Methodologies::Artificial Intelligence [Medical Subject Headings], Medicine, diagnostic/prognostic biomarker, CDKN2D, Receptor, EZH2, therapeutic target, General Medicine, Chemicals and Drugs::Biological Factors::Antigens::Antigens, Nuclear::Ki-67 Antigen [Medical Subject Headings], prostate cancer, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Castration resistant prostate cancer, G protein‐coupled receptor GPR107, Somatostatin‐system, G protein-coupled receptor GPR107, Therapeutic target, somatostatin-system, Neuronostatin, Check Tags::Male [Medical Subject Headings], Article, 03 medical and health sciences, splicing, LNCaP, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Androgens [Medical Subject Headings], Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Growth Processes::Cell Proliferation [Medical Subject Headings], Geographical Locations::Geographic Locations::Europe::Spain [Medical Subject Headings], Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::Down-Regulation [Medical Subject Headings], business.industry, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Urogenital Surgical Procedures::Castration [Medical Subject Headings], Neoplasias de la próstata resistentes a la castración, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, G-Protein-Coupled::Receptors, Somatostatin [Medical Subject Headings], lcsh:R, Andalucía, medicine.disease, Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Peptide Hydrolases::Endopeptidases::Metalloendopeptidases::Collagenases::Matrix Metalloproteinase 9 [Medical Subject Headings], Somatostatina, 030104 developmental biology, Chemicals and Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Peptide Hormones::Ghrelin [Medical Subject Headings], Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Neoplasm Proteins::Oncogene Proteins::Proto-Oncogene Proteins::Proto-Oncogene Proteins c-akt [Medical Subject Headings], Cancer research, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis [Medical Subject Headings], business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32081e3dff0846267fc03029a426d918Test
https://www.mdpi.com/2077-0383/9/6/1703Test

المؤلفون: Sanchez-Garrido, Miguel A., Tena-Sempere, Manuel

المساهمون: [Sanchez-Garrido,MA, Tena-Sempere,M] Instituto Maimónides de Investigación Biomédica de Cordoba (IMIBIC), Spain. [Sanchez-Garrido,MA, Tena-Sempere,M] Department of Cell Biology, Physiology, and Immunology, University of Cordoba, Spain. [Sanchez-Garrido,MA, Tena-Sempere,M] Hospital Universitario Reina Sofia, Cordoba, Spain. [Sanchez-Garrido,MA, Tena-Sempere,M] CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III Cordoba, Spain. [Tena-Sempere,M] FiDiPro Program, Institute of Biomedicine, University of Turku, FIN-20520 Turku, Finland., Research activities at the authors' laboratory related to the contents of this work were funded by grants BFU2017-83934-P (to MT-S, Ministry of Economy and Competitiveness, Spain, co-funded with EU funds from the FEDER Program), project PIE14-00005 (to MT-S, Flexi-Met, Carlos III Health Institute, Ministry of Health, Spain), and project PI-0358-2018-FIB (to MAS-G, FIBICO). CIBER is an initiative of the Carlos III Health Institute (Ministry of Health, Spain).

مصطلحات موضوعية: Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Mice [Medical Subject Headings], Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Metabolic Syndrome X [Medical Subject Headings], Obesidad, Péptido 1 similar al glucagón, Phenomena and Processes::Physiological Phenomena::Pharmacological Phenomena::Drug Resistance::Insulin Resistance [Medical Subject Headings], Insulin resistance, Diseases::Endocrine System Diseases::Gonadal Disorders::Disorders of Sex Development::Adrenogenital Syndrome::Hyperandrogenism [Medical Subject Headings], Poly-agonists, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Bariatrics::Bariatric Surgery [Medical Subject Headings], Resistencia a la insulina, Androgen excess, Anatomy::Tissues::Connective Tissue::Adipose Tissue [Medical Subject Headings], Diseases::Nutritional and Metabolic Diseases::Nutrition Disorders::Overnutrition::Obesity [Medical Subject Headings], Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Síndrome del ovario poliquístico, Check Tags::Female [Medical Subject Headings], PCOS, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Androgens [Medical Subject Headings], Organisms::Eukaryota::Animals [Medical Subject Headings], Obesity, GLP-1, Diseases::Female Urogenital Diseases and Pregnancy Complications::Female Urogenital Diseases::Genital Diseases, Female::Adnexal Diseases::Ovarian Diseases::Ovarian Cysts::Polycystic Ovary Syndrome [Medical Subject Headings]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______2636::74b3b7fec015e51cdcc61e6eed51babcTest
https://hdl.handle.net/10668/3630Test